Fortive Corporation FTV SPX
Technology · Scientific & Technical Instruments · United States
Fortive Corporation designs, develops, manufactures, and markets products, software, and services in the United States, China, and internationally. It operates through Intelligent Operating Solutions and Advanced Healthcare Solutions segments. The Intelligent Operating Solutions segment provides advanced instrumentation, software, and services, including maintenance, repair, measurement and condition monitoring, facility and asset lifecycle software applications, and connected worker safety and compliance solutions for manufacturing, process industries, healthcare, utilities and power, communications and electronics, and other industries. This segment markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, and SERVICECHANNEL brand names. The Advanced Healthcare Solutions segment provides critical workflow solutions comprising instrument sterilization, instrument tracking, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions under the ASP, CENSIS, FLUKE BIOMEDICAL, LANDAUER, and PROVATION brand names. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.
READ MORE ›$58.32
+10.64% 1Y
Market & Price
Market Cap
$17.78B
Current Price
$58.32
High / Low (52W)
$62.01 / $46.39
Beta
1.00
Valuation
Stock P/E
34.31
Industry PE
32.74
Forward P/E
18.13
PEG Ratio
0.98
Book Value
$19.91
Price to Book
2.93
P/S
4.20
EV/EBITDA
17.66
Dividend Yield
0.45%
Profitability & Returns
ROCE
7.61%
ROE
6.81%
ROA
3.25%
Profit Margin
12.84%
Op Margin
17.93%
EPS (Latest Qtr)
$0.44
EPS (TTM)
$1.70
Balance Sheet & Liquidity
Debt/Equity
0.59
Quick Ratio
0.53
Current Ratio
0.71
Debt
$3.58B
Total Assets
$11.74B
Current Assets
$1.61B
Working Capital
$-640.90M
Ownership
Promoter Holding
0.40%
Chg in Prom Hold
-
FII / Inst Holding
110.35%
Chg in FII Hold
0.04%
Financial Snapshot
Enterprise Value
$21.01B
Total Revenue (TTM)
$4.24B
EBITDA
$1.19B
Free Cash Flow
$953.61M
Operating Cash Flow
$1.08B
Shares Outstanding
304.86M
Gross Margin
63.25%
Payout Ratio
15.26%
Growth (CAGR)
Revenue 5Y
-10.62%
Profit 5Y
-8.46%
Revenue (YoY)
7.70%
Earnings (YoY)
-12.40%
PROS
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Revenue declined at -10.6% CAGR over 5 years.
- Earnings shrank at -8.5% CAGR over 5 years.
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Peer comparison
Peer companies in the same sector (Technology).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | FTV Fortive Corporation SPX | 58.32 | 34.31 | $17.78B | 0.45% | 7.61% | 6.81% | -10.62% | -8.46% |
| 2 | NVDA NVIDIA Corporation NDXSPXAI | 211.14 | 32.38 | $5.11T | 0.47% | 81.14% | 114.29% | 100.05% | 201.80% |
| 3 | AAPL Apple Inc. NDXSPX | 312.06 | 37.73 | $4.58T | 0.35% | 68.72% | 141.47% | 1.81% | 3.92% |
| 4 | MSFT Microsoft Corporation NDXSPXAI | 450.24 | 26.82 | $3.34T | 0.81% | 26.37% | 34.01% | 12.42% | 11.87% |
| 5 | TSM Taiwan Semiconductor Manufacturing Company Limited AI | 418.45 | 35.86 | $2.17T | 0.91% | 32.04% | 36.21% | 18.94% | 19.57% |
| 6 | MU Micron Technology, Inc. NDXSPXAI | 971.00 | 45.87 | $1.10T | 0.06% | 14.20% | 39.82% | 6.71% | -0.57% |
| 7 | AMD Advanced Micro Devices, Inc. NDXSPXAI | 516.10 | 172.61 | $841.55B | - | 6.33% | 8.06% | 13.64% | 48.64% |
| 8 | ORCL Oracle Corporation SPXAI | 225.78 | 40.46 | $649.35B | 0.89% | 13.07% | 57.57% | 10.59% | 22.81% |
| 9 | ASML ASML Holding N.V. NDXAI | 1,612.76 | 53.76 | $621.59B | 0.54% | 43.81% | 52.24% | 15.55% | 19.55% |
Ad space
Quarterly Results
Figures in USD.
| Metric | Apr 2016 | Jul 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Apr 2021 | Jul 2021 | Oct 2021 | Dec 2021 | Apr 2022 | Jul 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Apr 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | 1.32B | 1.40B | 1.46B | 1.58B | 1.49B | 1.60B | 1.60B | 1.76B | 980.40M | 1.17B | 1.15B | 1.26B | 1.11B | 1.04B | 1.16B | 1.32B | 1.26B | 1.32B | 1.30B | 1.37B | 1.38B | 1.46B | 1.46B | 1.46B | 1.53B | 1.49B | 984.20M | 1.02B | - | - | 993.10M | 1.52B | 1.03B | 1.12B | 1.07B | 1.07B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 355.60M | 623.10M | 377.90M | 413.60M | 393.90M | - |
| Gross Profit | 695.20M | 768.10M | 772.90M | 796.60M | 654.20M | 708.80M | 744.80M | 813.60M | 766.30M | 830.80M | 825.90M | 898.30M | 551.60M | 605.80M | 618.70M | 707.10M | 612.00M | 582.80M | 651.60M | 762.10M | 711.90M | 755.50M | 745.70M | 794.00M | 792.00M | 833.50M | 845.40M | 848.20M | 905.40M | 893.00M | 628.50M | 653.60M | - | - | 637.50M | 895.70M | 649.20M | 708.90M | 675.50M | 675.50M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 472.20M | 673.50M | 489.60M | 483.40M | 483.80M | - |
| Operating Income | 263.00M | 322.10M | 323.20M | 337.70M | 243.70M | 292.90M | 301.40M | 305.00M | 277.90M | 324.40M | 281.60M | 294.50M | 112.00M | 95.60M | 96.40M | 139.90M | 115.40M | 102.60M | 137.50M | 183.90M | 197.60M | 211.30M | 202.30M | 201.60M | 212.30M | 232.30M | 251.90M | 240.40M | 291.30M | 291.10M | 149.80M | 182.30M | - | - | 165.30M | 222.20M | 159.60M | 225.50M | 191.70M | 191.70M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 273.70M | 388.80M | 213.20M | 339.30M | 308.80M | - |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 37.00M | 33.10M | 32.00M | 32.10M | - | - | 31.60M | - |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 133.70M | 192.00M | 135.00M | 193.90M | 163.60M | - |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 21.10M | 25.40M | 18.00M | 2.40M | 27.20M | - |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 173.60M | 209.00M | 218.00M | 207.40M | 195.10M | - | - | 171.90M | 166.60M | 55.00M | 185.70M | 136.40M | 136.40M |
| Diluted EPS | 0.53 | 0.69 | 0.65 | 0.64 | 0.57 | 0.68 | 0.76 | 0.95 | 0.74 | 0.83 | 0.64 | 6.17 | 0.43 | 0.46 | 0.56 | 0.52 | 0.07 | 0.33 | 0.61 | 3.37 | 0.27 | 0.48 | 0.42 | 0.44 | 0.45 | 0.48 | 0.53 | 0.49 | 0.59 | 0.61 | 0.58 | 0.55 | - | - | 0.50 | 0.49 | 0.16 | 0.58 | 0.44 | 0.44 |
| R&D Expense | 93.70M | 96.70M | 95.20M | - | 96.20M | 99.10M | 102.00M | - | 99.90M | 101.90M | 103.70M | - | 109.00M | 117.40M | 119.10M | - | 80.80M | 77.40M | 79.20M | - | 86.20M | 87.80M | 87.80M | - | 99.10M | 100.10M | 101.10M | 100.10M | 100.10M | 98.40M | 104.10M | 101.10M | 62.00M | - | 64.00M | 109.20M | 62.00M | - | - | 66.50M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | 5.38B | 5.76B | 3.80B | 4.56B | 4.63B | - | 5.83B | 3.91B | 4.08B | 4.16B |
| Cost of Revenue | - | - | - | - | - | - | - | - | 2.46B | 1.44B | 1.46B | 1.52B |
| Gross Profit | 3.05B | 3.00B | 2.69B | 2.92B | 2.19B | 2.48B | 2.61B | - | 3.36B | 2.48B | 2.62B | 2.64B |
| Operating Expenses | - | - | - | - | - | - | - | - | 2.36B | 1.90B | 1.90B | 1.92B |
| Operating Income | 1.25B | 1.27B | 1.06B | 1.14B | 645.30M | 443.90M | 539.40M | - | 1.01B | 574.00M | 716.30M | 720.20M |
| EBITDA | - | - | - | - | - | - | - | - | 1.44B | 982.80M | 1.09B | 1.16B |
| Interest Expense | - | - | - | - | - | - | - | - | 98.30M | 123.50M | 152.80M | 120.50M |
| Pretax Income | - | - | - | - | - | - | - | - | 873.50M | 433.10M | 506.30M | 602.20M |
| Tax Provision | - | - | - | - | - | - | - | - | 118.30M | 24.70M | 23.80M | 69.50M |
| Net Income | - | - | - | - | - | - | - | - | 755.20M | 865.80M | 832.90M | 579.20M |
| Diluted EPS | 2.56 | 2.50 | 2.51 | 2.96 | 8.21 | 1.97 | 4.49 | - | 2.10 | 2.43 | 2.36 | 1.73 |
| R&D Expense | 387.60M | 377.70M | 351.00M | 369.30M | 278.10M | 320.30M | 320.70M | 354.80M | 401.50M | 237.00M | 251.30M | 259.20M |
Compounded Sales Growth
| 5 Years: | -10.62% |
| 1 Year: | 7.70% |
Compounded Profit Growth
| 5 Years: | -8.46% |
| 1 Year: | -12.40% |
Stock Price Performance
| 1 Year: | +10.64% |
| 6 Months: | +9.70% |
| 3 Months: | -1.38% |
| 1 Month: | -5.55% |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | 7.36B | 7.21B | 8.19B | 10.50B | 12.91B | 17.44B | 16.05B | - | 15.89B | 16.91B | 17.02B | 11.74B |
| Current Assets | - | - | - | - | - | - | - | - | - | 2.48B | 3.67B | 2.59B | 1.61B |
| Cash & Equivalents | 0 | 0 | 0 | 803.20M | 962.10M | 1.18B | 1.21B | 1.82B | - | 709.20M | 1.89B | 813.30M | 375.50M |
| Inventory | - | - | - | - | - | - | - | - | - | 536.70M | 536.90M | 269.80M | 291.80M |
| Receivables | - | - | - | - | - | - | - | - | - | 958.50M | 960.80M | 661.30M | 683.60M |
| Total Liabilities | - | - | - | - | - | - | - | - | - | 6.20B | 6.59B | 6.82B | 5.28B |
| Current Liabilities | - | - | 1.32B | 1.47B | 1.60B | 2.19B | 3.47B | 2.86B | - | 2.73B | 1.79B | 2.24B | 2.25B |
| Long Term Debt | - | - | 0 | 3.36B | 4.06B | 2.97B | 4.83B | 2.83B | - | 2.25B | 3.65B | 3.33B | 2.31B |
| Total Debt | - | - | - | - | - | - | - | - | - | 3.42B | 3.81B | 3.71B | 3.31B |
| Total Equity | - | - | 5.18B | 2.69B | 3.79B | 6.60B | 7.39B | 8.96B | - | 9.68B | 10.32B | 10.19B | 6.45B |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | 361.50M | 363.70M | 366.60M | 369.60M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 946.70M | 1.01B | 1.14B | 1.18B | 1.34B | 1.27B | 1.44B | - | 1.30B | 1.35B | 1.53B | 1.08B |
| Investing Cash Flow | -291.10M | -174.10M | -310.80M | -1.67B | -1.97B | -4.05B | -148.40M | - | -102.50M | -195.40M | -1.80B | -135.40M |
| Financing Cash Flow | -655.60M | -834.90M | 3.80M | 599.70M | 879.10M | 2.80B | -696.10M | - | -1.27B | 32.30M | -792.70M | -1.39B |
| Capital Expenditure | -102.60M | -120.10M | -110.10M | -111.10M | -69.90M | -74.50M | -75.70M | -50.00M | -95.80M | -107.80M | -120.40M | - |
| Free Cash Flow | 844.10M | 888.90M | 1.03B | 1.07B | 1.27B | 1.20B | 1.36B | - | 1.21B | 1.35B | 1.53B | 1.08B |
| Net Change in Cash | - | - | - | - | - | - | - | - | -72.30M | 1.19B | -1.06B | -438.80M |
| Share Buybacks | - | - | - | - | - | - | 0 | 0 | 442.90M | 272.90M | 889.60M | 1.61B |
| Dividends Paid | 0 | 0 | 48.40M | 97.20M | 96.60M | - | - | - | 99.50M | 102.00M | 111.20M | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | 49.9% | 50.8% | 57.5% | 54.4% | 56.3% | - | 57.7% | 63.3% | 64.2% | 63.5% |
| Operating Margin % | - | - | 19.7% | 19.9% | 17.0% | 9.7% | 11.6% | - | 17.3% | 14.7% | 17.6% | 17.3% |
| Net Margin % | - | - | - | - | - | - | - | - | 13.0% | 22.1% | 20.4% | 13.9% |
| ROE % | - | - | - | - | - | - | - | - | 7.8% | 8.4% | 8.2% | 9.0% |
| ROCE % | - | 21.6% | 15.8% | 12.8% | 6.0% | 3.2% | 4.1% | - | 7.6% | 3.8% | 4.8% | 7.6% |
Shareholding Pattern
Insiders
0.40%
Institutions
110.35%
Public Float
110.79%
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Dodge & Cox Inc. | 14.16% | 43.16M | $2.52B |
| 2 | Blackrock Inc. | 10.37% | 31.63M | $1.84B |
| 3 | Price (T.Rowe) Associates Inc | 7.78% | 23.72M | $1.38B |
| 4 | Viking Global Investors, L.P. | 7.37% | 22.48M | $1.31B |
| 5 | Vanguard Capital Management LLC | 6.63% | 20.21M | $1.18B |
| 6 | State Street Corporation | 4.46% | 13.61M | $793.75M |
| 7 | Vanguard Portfolio Management LLC | 4.31% | 13.15M | $767.16M |
| 8 | Flossbach von Storch SE | 3.90% | 11.90M | $694.17M |
| 9 | Geode Capital Management, LLC | 3.03% | 9.25M | $539.38M |
| 10 | Barrow, Hanley Mewhinney & Strauss, LLC | 3.01% | 9.18M | $535.48M |
Analyst View
Loading analyst coverage…
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for FTV
No recent headlines available.